HCV and HIV Clinical Trials Services
Benefit from Virco’s proven track record in HCV or HIV clinical trials for robust and sensitive virology diagnostic solutions.
Virco brings a legacy of tried and true experience when it comes to clinical trials support and services for chronic infectious diseases. Our clinical trial services for sequencing, genotyping, subtyping, phenotyping and deep sequencing are developed completely in-house and are:
- Highly advanced and automated
- Fully validated to regulatory standards and practice (e.g. GCP, etc.)
- Subject to stringent quality controls
- Performed in a fully accredited laboratory by highly skilled specialist technicians
Click here for a list of all our Lab accreditations
HCV Clinical Trial Services
There are nearly 40 direct acting antivirals (DAA) undergoing clinical trial evaluation in HCV clinical trials. [1] Virco’s HCV clinical trial services support the development and evaluation of innovative DAAs.
-
Virco’s collective years of characterizing HIV resistance benefits the HCV clinical trial services thanks to significant insights in:
- Molecular virology and designing relevant assays
- Sequencing techniques and applications
- Viral phenotyping
HIV Early Development and Clinical Trial Services
- A legacy of dedicated experience with HIV and support to the HIV community
- Insights gathered over the product development continuum from “the bench to the clinic”
- Collaborations forged with leading HIV researchers, product developers, scientists, and informatics specialists
Data Reporting
Virco facilitates clinical trial data transfers to the sponsor or CRO’s specifications with timely results, clean, high quality data and processes in place to keep it secure:
- Processes, SOPs established to ensure quality, validation and documentation (e.g. GCP)
- Secure and structured to be client-friendly
- Allows flexibility for smooth hand-offs
- Established computerized system validation methodology
- All data reporting systems are 21 CFR 11 compliant
